Last reviewed · How we verify
Huaren Peritoneal Dialysate
Huaren Peritoneal Dialysate is a solution used in peritoneal dialysis to remove waste products and excess fluid from the blood through the peritoneal membrane.
Huaren Peritoneal Dialysate is a solution used in peritoneal dialysis to remove waste products and excess fluid from the blood through the peritoneal membrane. Used for End-stage renal disease requiring peritoneal dialysis.
At a glance
| Generic name | Huaren Peritoneal Dialysate |
|---|---|
| Sponsor | Chinese PLA General Hospital |
| Drug class | Peritoneal dialysis solution |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
Mechanism of action
Peritoneal dialysate works by establishing a concentration gradient across the peritoneal membrane, allowing uremic toxins and excess electrolytes to diffuse from the blood into the dialysate solution, which is then drained from the peritoneal cavity. The solution typically contains glucose or other osmotic agents to facilitate ultrafiltration and fluid removal. This process replaces the filtration function of failed kidneys in patients with end-stage renal disease.
Approved indications
- End-stage renal disease requiring peritoneal dialysis
Common side effects
- Peritonitis
- Hyperglycemia
- Electrolyte imbalances
- Abdominal discomfort
Key clinical trials
- Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate (PHASE4)
- A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Huaren Peritoneal Dialysate CI brief — competitive landscape report
- Huaren Peritoneal Dialysate updates RSS · CI watch RSS
- Chinese PLA General Hospital portfolio CI